| Filed On | Filing |
|---|---|
| 16 Nov 2026 |
Form 4: Beindorff Michael A, Director
Sold 10,000 shares ($48.9K) |
| 12 Nov 2026 | 8-K: Submission of Matters to a Vote of Security Holders |
| 12 Nov 2026 | 144 |
| 09 Nov 2026 |
Form 4: Beindorff Michael A, Director
Received 17,888 shares as a grant or award ($105K) |
| 09 Nov 2026 |
Form 4: Anbalagan Rajendran, Director
Received 17,888 shares as a grant or award ($105K) |
| 09 Nov 2026 |
Form 4: Lewis Darwin, Director
Received 17,888 shares as a grant or award ($105K) |
| 09 Nov 2026 |
Form 4: Greer Raymond B, Director
Received 17,888 shares as a grant or award ($105K) |
| 09 Nov 2026 |
Form 4: Dayton Judd, Director
Received 17,888 shares as a grant or award ($105K) |
| 09 Nov 2026 |
8-K: Results of Operations and Financial Condition
Salt Lake City, UT, November 9, 2026, LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for i... |
| 09 Nov 2026 | 10-Q |
| 22 Oct 2026 | SCHEDULE 13G/A |
| 09 Oct 2026 |
Form 4: Cunningham Kristen, Chief Sales Officer
Received 32,850 shares as a grant or award · Granted 49,275 Performance Restricted Stock Units |
| 09 Oct 2026 |
Form 4: Aure Carl, Chief Financial Officer
Received 35,749 shares as a grant or award · Granted 53,623 Performance Restricted Stock Units |
| 09 Oct 2026 |
Form 4: Moorehead Terrence, Director
Received 193,237 shares as a grant or award · Granted 289,855 Performance Restricted Stock Units |
| 05 Oct 2026 |
Form 4: Aure Carl, Chief Financial Officer
Gave up 460 shares to cover exercise price or tax ($2.87K) |
| 05 Oct 2026 |
Form 4: Cunningham Kristen, Chief Sales Officer
Gave up 637 shares to cover exercise price or tax ($3.97K) |
| 05 Oct 2026 |
8-K: Amendments to Articles/Bylaws; Change in Fiscal Year
On September 29, 2026, in order to align the fiscal year of LifeVantage Corporation (the “Company”) with the calendar year and better coordinate the Company’s financial reporting and operational management processes, the Board of Directo... |
| 18 Sep 2026 | ARS |
| 18 Sep 2026 | DEFA14A |
| 18 Sep 2026 |
Proxy statement: annual meeting on November 5, 2026
say-on-pay vote |
Loading...